Difference between revisions of "Clinical trials"
Jump to navigation
Jump to search
m |
|||
| Line 4: | Line 4: | ||
:*[http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf CTCAE 5x7" small booklet format] [http://hemonc.org/docs/CTCAE4_5x7.pdf local backup] | :*[http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf CTCAE 5x7" small booklet format] [http://hemonc.org/docs/CTCAE4_5x7.pdf local backup] | ||
:*[http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf CTCAE 8.5x11" letter size format] [http://hemonc.org/docs/CTCAE4_8.5x11.pdf local backup] | :*[http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf CTCAE 8.5x11" letter size format] [http://hemonc.org/docs/CTCAE4_8.5x11.pdf local backup] | ||
| − | |||
Revision as of 06:31, 27 April 2017
- ClinicalTrials.gov
- Information & clinical trials by mutation type: My Cancer Genome
- Adverse event grading for clinical trials: Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC)